We are live on ! Find out more
IMCR icon

Immunocore
IMCR

47 hedge funds and large institutions have $617M invested in Immunocore in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

10% more capital invested

Capital invested by funds: $561M → $617M (+$56.2M)

4% more funds holding

Funds holding: 45 → 47 (+2)

4.08% more ownership

Funds ownership: 34.69% → 38.78% (+4.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
47
Holders Change
+2
Holders Change %
+4.44%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
15
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$32M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$25.7M
3
APM
Avidity Partners Management
Texas
+$16.7M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$8.04M
5
First Manhattan
First Manhattan
New York
+$6.68M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$14.1M
2
BlackRock
BlackRock
New York
-$8.52M
3
TCM
Tybourne Capital Management
Hong Kong
-$5.4M
4
Citadel Advisors
Citadel Advisors
Florida
-$971K
5
JGC
J. Goldman & Co
New York
-$652K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$93.4M – – –
RSCM
2
Rock Springs Capital Management
Maryland
$90.6M +$1.7M +50,370 +2%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$80.8M +$32M +949,142 +77%
RI
4
RTW Investments
New York
$46.2M – – –
APM
5
Avidity Partners Management
Texas
$40.6M +$16.7M +494,600 +82%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$39M +$25.7M +760,563 +261%
GA
7
General Atlantic
New York
$35.2M – – –
BlackRock
8
BlackRock
New York
$30.7M -$8.52M -252,322 -23%
BCPEMI
9
Bain Capital Public Equity Management II
Massachusetts
$23.7M +$5.52M +163,651 +34%
GF
10
Gates Foundation
Washington
$21.4M – – –
PA
11
Perceptive Advisors
New York
$14.8M – – –
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$13.4M -$178K -5,278 -1%
Thrivent Financial for Lutherans
13
Thrivent Financial for Lutherans
Minnesota
$13M +$47.3K +1,400 +0.4%
Massachusetts Financial Services
14
Massachusetts Financial Services
Massachusetts
$12.4M +$8.04M +238,286 +245%
HA
15
HHLR Advisors
Cayman Islands
$10.3M – – –
AG
16
Artal Group
Luxembourg
$7.41M – – –
First Manhattan
17
First Manhattan
New York
$7.34M +$6.68M +197,999 New
Principal Financial Group
18
Principal Financial Group
Iowa
$6.86M +$264K +7,820 +4%
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$5.52M +$2.57M +76,100 +104%
Millennium Management
20
Millennium Management
New York
$3.48M -$314K -9,309 -9%
RPAM
21
Rhenman & Partners Asset Management
Sweden
$3.34M – – –
PC
22
Pier Capital
Connecticut
$2.91M +$2.65M +78,514 New
SB
23
Samsara BioCapital
California
$2.37M – – –
AA
24
ALPS Advisors
Colorado
$1.99M -$122K -3,610 -6%
OFM
25
Omega Fund Management
Massachusetts
$1.91M – – –
1
2 3

IMCR Hedge Fund Activity: Q3 2021 in Review

47 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Immunocore (IMCR) for Q3 2021, worth a combined $617M — up 10% from $561M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new IMCR positions and 5 closed out — a net gain of 2 holders — while 15 added to existing stakes and 8 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $32M. The largest seller was Deerfield Management, exiting entirely with an estimated $14.1M sold.

  • 47 institutional investors held Immunocore (IMCR) as of Q3 2021, up from 45 in Q2 2021.
  • Funds reported $617M of Immunocore stock for Q3 2021, up 10% quarter-over-quarter.
  • 7 funds opened new Immunocore positions in Q3 2021 and 5 closed out, a net change of +2 holders.
  • The largest Immunocore buyer in Q3 2021 was Fidelity Investments, an estimated $32M added.
  • The largest Immunocore seller in Q3 2021 was Deerfield Management, an estimated $14.1M sold.

Based on aggregated 13F filings for Q3 2021.